My HbA1c was 6.8% last December, and as of April this year my HbA1c is 5.3%. Am I diabetic? I am taking 500 mg of metformin and 20 mg of teneligliptin 20 mg/dL.
Fasting blood glucose is 115 mg/dL, and after exercising/walking for 30 minutes, my blood glucose is 134 mg/dL. Does this put me at risk for being diagnosed with diabetes? Can you help me solve this issues?
If your Physician has put you on metformin, it usually means they are trying to stabilize your blood sugars. An A1C of 6.8% means your average blood sugar reading for the last 60 to 90 days is 148 mg/dL. People without diabetes experience blood sugars between 70 and 140 mg/dL.
Metformin was introduced to the U.S. market from France in 1995. It’s discovery dates back to 1922, and it is the least expensive medication both domestically and internationally. The World Health Organization considers it a necessary drug for therapy with an affordable price tag for most patients. Even in the U.S. metformin is the least expensive medication for people living with type 2 diabetes.
How it Works
Metformin is effective as the first line of therapy for insulin resistant type 2 diabetes patients. It helps with blood sugars because when you take metformin, the liver produces less glucose with a secondary effect of increasing insulin sensitivity. The oral medication has some side effects that can be intolerable; gas, abdominal pain, diarrhea, and nausea. Everybody responds to the medication differently. You may have been lucky and experienced none of these side effects.
It is important to mention, sometimes people are allergic to the medication and have to go to a compound pharmacist to make a custom metformin cream that is tolerable for the patient and helps maintain normal blood sugar levels.
Over time, metformin can become less efficient in preventing high blood sugars, even after you watch what you eat and exercise. Augmenting metformin with anther medication to achieve healthy blood sugar levels is the second line of therapy.
Teneligliptin is Dipeptidyl Peptidase-4 also known as a (DPP-4) inhibitor. It is prescribed when a patient living with diabetes is unable to maintain normal blood sugars with diet, exercise and an anti-diabetic medication like metformin.
The DPP-4 Inhibitor teneligliptin was approved in Japan in 2012. It is marketed in Korea, India, and Japan.
In the U.S. we do have other DPP-4 Inhibitors physicians prescribe; JANUVIA, Onglyza, Tradjenta, and Jentadueto X.
Teneligliptin Works Differently Then Metformin
Metformin stimulates your pancreas to make more insulin while the DDP-4 inhibitors work by increasing hormones that stimulate your pancreas to produce more insulin and stimulate the liver to produce less glucose.
Your Fasting Blood Sugars
Your blood glucose readings of 115mg/dL and 134 mg/dL are what you would expect from a person with or without diabetes as it falls within the 70 to 180 range. Where it can be confusing is when you consistently experience “normal” blood sugars. Keep in mind the bllod sugar range for people without diabetes is less than 140 and for people with diabetes is less than 180. The reality is that your blood sugars are not high because of the two prescriptions you are taking in addition to exercising.
Kudos for a job well done. You have found the perfect balance with exercise and the two medications in preventing high blood sugars. Your results are phenomenal. Keep doing what your physician recommends. You are a doctor’s dream, achieving blood sugar reading in the non-diabetic range, assuring you the risk for diabetes complications is less likely in the long run.
Nadia’s feedback on your question is in no way intended to initiate or replace your healthcare professional’s therapy or advice. Please check in with your medical team to discuss your diabetes management concerns.
AskNadia and receive her unique perspective on your question. Or share your story with us.
Nadia was not only born into a family with diabetes but also married into one. She was propelled at a young age into “caretaker mode,” and with her knowledge of the scarcity of resources, support, and understanding for people with diabetes, co-founded Diabetes Interview, now Diabetes Health magazine.
Nadia’s Blog is named the “Best Diabetes Blog for 2017” by Healthline. She has also received 19 nominations for her work as a diabetes advocate. She has been featured on ABC, NBC, CBS, and other major cable networks. Her publications, medical supply business, and website have been cited, recognized and published in the San Francisco Chronicle, The Wall Street Journal, Ann Landers advice column, former Chrysler chairman Lee Iacocca, Entrepreneur magazine, Houston News, Phili.com, Brand Week, Drug Topics, and many other media outlets.